North America Transfection Market, By Type (Transient Transfection, Stable Transfection), Methods (Non-Viral Methods, Viral Methods), CRISPR Transfection Methods (Non-Viral Methods, Viral Methods), Products (Reagent & Kits, Instrument, Software), Organism (Mammalian Cells, Plants, Fungi, Virus, Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), Others), Application (In Vitro Application, In Vivo Application, Bioproduction, Others), Stage (Research, Preclinical, Clinical Phases, Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, Others), Distribution Channel (Direct Tender, Retail Sales, Others) – Industry Trends and Forecast to 2030.
North America Transfection Market Analysis and Size
The market for transfection will enhance rapidly because of the increasing cancer prevalence and increased research and development in cell-based therapies. According to the Centers for Disease Control and Prevention's March 2022 publication, 6 out of every 10 adults in the U.S. have a chronic disease, and 4 out of every 10 have two or more chronic diseases. Numerous government organizations take several initiatives in this regard to amplify the transfection market's growth.
Data Bridge Market Research analyses that the transfection market, which was USD 400 million in 2022, is expected to reach USD 797.03 million by 2030, at a CAGR of 9% from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Transfection Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Transient Transfection, Stable Transfection), Methods (Non-Viral Methods, Viral Methods), CRISPR Transfection Methods (Non-Viral Methods, Viral Methods), Products (Reagent & Kits, Instrument, Software), Organism (Mammalian Cells, Plants, Fungi, Virus, Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), Others), Application (In Vitro Application, In Vivo Application, Bioproduction, Others), Stage (Research, Preclinical, Clinical Phases, Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, Others), Distribution Channel (Direct Tender, Retail Sales, Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America
|
|
Market Players Covered
|
Lonza (Switzerland), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN (Germany), Inovio Pharmaceuticals (U.S.), Polyplus Transfection (France), Mirus Bio LLC (U.S.), Takara Bio Inc. (Japan), SignaGen Laboratories (U.S.), MaxCyte, Inc. (U.S.), Genlantis Inc. (U.S.), Altogen Biosystems (U.S.), OZ Biosciences (U.S.), Boca Scientific, Inc. (U.S.), Biontex Laboratories GmbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
The transfection method is widely used to introduce RNA, DNA, or protein products in cells to change the phenotype and genotype of the organism. The transfection method includes new gene transfer or transferring a gene construct, such as clustered regularly interspaced short palindromic repeats (CRISPR), for genome editing purposes. Transfection has numerous applications in gene therapy, immunotherapy, and cell therapy. It involves both non-viral and viral-mediated transfection.
North America Transfection Market Dynamics
Drivers
- A rise in Chronic Diseases
There is an increasing incidence of chronic diseases that leads to market growth. Around 133 million U.S. citizens suffer from at least one chronic illness, such as hypertension, heart disease, and arthritis. In 2018, 51.8% of U.S. adults had at least 1 chronic condition, and 27.2% suffered from multiple chronic conditions. According to CDC, 6 in 10 adults in the U.S. currently live with a chronic disease such as heart disease, cancer, or diabetes. This increasing incidence leads to higher transfection applications and market growth as it will help in modifying the host cell’s genetic system and improve the immune system of the patient. Thus, this factor leads to the market growth.
- Increase in Cancer Cases
The growing burden of cancer among the U.S. population is one of the top factors responsible for market growth. For instance, according to the data from the American Cancer Society published in 2022, the expected number of new cancer cases for 2022 is around 2 million. Among the cancer cases, breast cancer and cancers of the genital system are anticipated to be highly prevalent. Transfection technologies are hugely used in cancer therapeutics, which is anticipated to boost the growth of the market studied in the U.S.
Opportunities
- Technological Advancements Associated With Transfection Method
Several new technologies are developed concerning transfection that leads to market growth. New launches in reagent-based transfection technologies are increasing the market growth. For instance, Polyplus launched a transfection reagent for large-scale viral vector production in 2021. The new launch from Polyplus can contribute considerably to simplifying the process of producing viral vectors due to the increasing demand for viral vector production. Thus, this leads to market growth.
Restraints/Challenges
- The Increasing Cost Of Transfection Technologies
A higher cost of transfection technologies leads to market hindrance. Different technologies are developed, which are expensive, and the instruments, kits and reagents are also expensive enough to further lead to market growth. They will further challenge the growth of the transfection market during the forecast period.
This transfection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transfection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Transfection Market Scope
The transfection market is segmented on the basis of type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Transient Transfection
- Stable Transfection
Method
- Non-Viral Methods
- Viral
CRISPR Transfection Methods
- Non-Viral Methods
- Viral Methods
End-User
- Reagent and Kits
- Instrument
- Software
Organism
- Mammalian Cells
- Plants
- Fungi
- Virus
- Bacteria
Types of Molecule
- Plasmid DNA
- Small Interfering RNA (siRNA)
- Proteins, DNA Oligonucleotides
- Ribonucleoprotein Complexes (RNPs)
- Others
Stage
- Research
- Preclinical
- Clinical Phases
- Commercial
End User
- Biopharma
- Contract Research Organizations (CROs)
- Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs)
- Academia
- Hospitals
- Clinical Labs
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Transfection Market Regional Analysis/Insights
The transfection market is analyzed and market size insights and trends are provided by type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel as referenced above.
The countries covered in the transfection market report are U.S., Canada and Mexico in North America
The U.S. dominates the transfection market due to growing government support and the increasing need for chimeric genes for several therapeutic purposes. Also, this region has increased the use of cell-based products requiring transfection methods for treating chronic diseases such as tuberculosis, cancer, and cardiovascular diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of north america brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The transfection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transfection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transfection market. The data is available for historic period 2011-2021.
Competitive Landscape and Transfection Market Share Analysis
The transfection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, north america presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to transfection market.
Some of the major players operating in the transfection market are:
- Lonza (Switzerland)
- Promega Corporation (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- QIAGEN (Germany)
- Inovio Pharmaceuticals (U.S.)
- Polyplus Transfection (France)
- Mirus Bio LLC (U.S.)
- Takara Bio Inc. (Japan)
- SignaGen Laboratories (U.S.)
- MaxCyte, Inc. (U.S.)
- Genlantis Inc. (U.S.)
- Altogen Biosystems (U.S.)
- OZ Biosciences (U.S.)
- Boca Scientific, Inc. (U.S.)
- Biontex Laboratories GmbH (Germany)
SKU-